Soft Tissue Sarcoma Treatment Market

The soft tissue sarcoma treatment market encompasses therapies for rare cancers affecting connective tissues like muscles, fat, and blood vessels. Primary customers are healthcare providers, with hospitals serving as the main treatment centers. Key growth drivers include the increasing incidence of cancer, significant advancements in targeted therapy and immunotherapy, and a rise in research and development activities, all of which are improving patient outcomes.